UK launch for Ferring’s Rekovelle
Ferring’s novel human recombinant follicle stimulating hormone (human rFSH) Rekovelle has now been launched across the UK for use in controlled ovarian stimulation.
Read More
Tag: Rekovelle
EU nod for Ferring’s Rekovelle
Ferring’s Rekovelle has been approved by European regulators for controlled ovarian stimulation in women undergoing assisted reproductive technologies.
Read More
Eight medicines win CHMP nod
Eight medicines have taken a big leap towards being approved in Europe having won the support of the European Medicines Agency’s Committee for Medicinal Products for Human Use.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
